NO20015729L - Expression products of genes involved in diseases related to cholesterol metabolism - Google Patents

Expression products of genes involved in diseases related to cholesterol metabolism

Info

Publication number
NO20015729L
NO20015729L NO20015729A NO20015729A NO20015729L NO 20015729 L NO20015729 L NO 20015729L NO 20015729 A NO20015729 A NO 20015729A NO 20015729 A NO20015729 A NO 20015729A NO 20015729 L NO20015729 L NO 20015729L
Authority
NO
Norway
Prior art keywords
genes involved
diseases related
expression products
cholesterol metabolism
cholesterol
Prior art date
Application number
NO20015729A
Other languages
Norwegian (no)
Other versions
NO20015729D0 (en
Inventor
Patrice Denefle
Marie-Francoise Rosier-Montus
Isabelle Arnould-Reguigne
Catherine Prades
Christian Clepet
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9906587A external-priority patent/FR2794131B1/en
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20015729D0 publication Critical patent/NO20015729D0/en
Publication of NO20015729L publication Critical patent/NO20015729L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20015729A 1999-05-25 2001-11-23 Expression products of genes involved in diseases related to cholesterol metabolism NO20015729L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9906587A FR2794131B1 (en) 1999-05-25 1999-05-25 GENE EXPRESSION PRODUCTS INVOLVED IN CONDITIONS ASSOCIATED WITH THE METABOLISM OF CHOLESTEROL
US13945099P 1999-06-16 1999-06-16
PCT/FR2000/001426 WO2000071710A2 (en) 1999-05-25 2000-05-25 Expression products of genes involved in diseases related to cholesterol metabolism

Publications (2)

Publication Number Publication Date
NO20015729D0 NO20015729D0 (en) 2001-11-23
NO20015729L true NO20015729L (en) 2002-01-22

Family

ID=26234967

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015729A NO20015729L (en) 1999-05-25 2001-11-23 Expression products of genes involved in diseases related to cholesterol metabolism

Country Status (11)

Country Link
EP (1) EP1183350A2 (en)
JP (1) JP2003518918A (en)
KR (1) KR20020033627A (en)
AU (1) AU4931800A (en)
BR (1) BR0010916A (en)
CA (1) CA2371500A1 (en)
HU (1) HUP0203164A2 (en)
IL (1) IL145835A0 (en)
MX (1) MXPA01011882A (en)
NO (1) NO20015729L (en)
WO (1) WO2000071710A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6617122B1 (en) 1999-03-15 2003-09-09 Xenon Genetics, Inc. Process for identifying modulators of ABC1 activity
AU2001279024B2 (en) 2000-08-01 2007-05-17 Amgen Inc. C3b/C4b complement receptor-like molecules and uses thereof
AT413701B (en) * 2001-11-06 2006-05-15 Bmt Medizinische Forschung Und STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF CDW92
JP5618172B2 (en) 2007-01-05 2014-11-05 国立大学法人東京大学 Diagnosis and treatment of cancer using anti-PRG-3 antibody
CN102112492B (en) 2007-11-14 2015-02-25 中外制药株式会社 Diagnosis and treatment of cancer using anti-GPR49 antibody

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020165A2 (en) * 1996-11-06 1998-05-14 Whitehead Institute For Biomedical Research Biallelic markers

Also Published As

Publication number Publication date
WO2000071710A3 (en) 2001-05-17
NO20015729D0 (en) 2001-11-23
MXPA01011882A (en) 2002-05-06
CA2371500A1 (en) 2000-11-30
AU4931800A (en) 2000-12-12
KR20020033627A (en) 2002-05-07
EP1183350A2 (en) 2002-03-06
JP2003518918A (en) 2003-06-17
WO2000071710A2 (en) 2000-11-30
HUP0203164A2 (en) 2002-12-28
BR0010916A (en) 2002-02-19
IL145835A0 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
NO20001244L (en) Method of delivering genes to antigen presenting cells in the skin
NO20016046L (en) Administration of non-oral androgenic steroids to women
DE60043692D1 (en) ACYL DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO VLA-4
WO2000045317A8 (en) Method for simulation of human response to stimulus
NO20030506D0 (en) Pharmaceutical Compositions of Cholesterol Ester Transfer Protein Inhibitors
IN1998CH01219A (en) Production of polyunsaturated fatty acid by expression of polyketide-like synthesis genes in plants
NO20015112D0 (en) Use of glycosylceramide synthesis inhibitors in therapy
PT1173434E (en) NEW PHARMACEUTICAL PRODUCT
NO20015729D0 (en) Expression products of genes involved in diseases related to cholesterol metabolism
NO983775D0 (en) Regulation of gene expression in eukaryotes
AU2001238511A1 (en) Cosmetics to support skin metabolism
GB9706381D0 (en) Improvements relating to the specificity of gene expression
AU2002219988A1 (en) Compositions and methods relating to breast specific genes and proteins
AU2513100A (en) Method and system for buyer-initiated aggregating of buyers to obtain desired products at discounted prices
AU2001297741A1 (en) Compositions and methods relating to breast specific genes and proteins
IL146237A0 (en) Autotaxin variants and uses to treat diseases of metabolism
ZA200109129B (en) Expression products of genes involved in diseases related to cholesterol metabolism.
NO20011103D0 (en) Local delivery of medicines to the heart
AU2003252979A1 (en) Improvements in or relating to the heating of products
NO20030052L (en) Genes and their gene products relevant to microsatellite unstable (MSI +) tumors
NO20014540D0 (en) Use of inulin in meat products
AU1520599A (en) Somatic transfer of modified genes to predict drug effects
DE69828876D1 (en) COMPOSITION FOR THE TREATMENT OF DISEASES ARISING WITH APOPTOSIS
AU2002243300A1 (en) Human genes and gene expression products isolated from human prostate
NO20016089D0 (en) Nucleic and protein acids corresponding to the human gene ABC1

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application